Klenk, Christian http://orcid.org/0000-0002-4664-8107
Erber, Johanna
Fresacher, David http://orcid.org/0000-0002-7650-8033
Röhrl, Stefan http://orcid.org/0000-0001-6277-3816
Lengl, Manuel
Heim, Dominik http://orcid.org/0000-0001-8463-1544
Irl, Hedwig http://orcid.org/0000-0001-8042-1910
Schlegel, Martin http://orcid.org/0000-0001-7054-9566
Haller, Bernhard http://orcid.org/0000-0002-9723-393X
Lahmer, Tobias
Diepold, Klaus
Rasch, Sebastian http://orcid.org/0000-0002-7917-8017
Hayden, Oliver http://orcid.org/0000-0002-2678-8663
Article History
Received: 15 April 2023
Accepted: 25 October 2023
First Online: 7 November 2023
Competing interests
: The authors declare the following competing interests: T.L. received travel grants from Gilead, Pfizer, and M.S.D. and lecture fees from CytoSorbents. S.Ra received travel grants from Gilead and lecture fees from CytoSorbents. J.E. reports non-financial support from Gilead Sciences, ViiV Healthcare and Pfizer. All other authors declare no conflict of interest.